Article ; Online: Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC.
2021 Volume 56, Issue 4, Page(s) 503–504
MeSH term(s) | Acrylamides/pharmacology ; Acrylamides/therapeutic use ; Aniline Compounds/pharmacology ; Aniline Compounds/therapeutic use ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/genetics ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-ret |
---|---|
Chemical Substances | Acrylamides ; Aniline Compounds ; Protein Kinase Inhibitors ; osimertinib (3C06JJ0Z2O) ; EGFR protein, human (EC 2.7.10.1) ; ErbB Receptors (EC 2.7.10.1) ; Proto-Oncogene Proteins c-ret (EC 2.7.10.1) ; RET protein, human (EC 2.7.10.1) |
Language | English |
Publishing date | 2021-08-03 |
Publishing country | United States |
Document type | Letter |
ZDB-ID | 1101370-9 |
ISSN | 1542-6270 ; 1060-0280 |
ISSN (online) | 1542-6270 |
ISSN | 1060-0280 |
DOI | 10.1177/10600280211036909 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 900: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.